Cargando…

Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.

Breast cancer cells are known to express various proteolytic enzymes, which make them invasive and favour their dissemination to distant sites. However, it is unclear whether breast cancer cells have the ability to produce polymorphonuclear leucocyte elastase (PMN-E). We measured immunoreactive (ir)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, J. I., Ogawa, M., Ikei, S., Omachi, H., Yamashita, S. I., Saishoji, T., Nomura, K., Sato, H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968785/
https://www.ncbi.nlm.nih.gov/pubmed/8286213
_version_ 1782134816337035264
author Yamashita, J. I.
Ogawa, M.
Ikei, S.
Omachi, H.
Yamashita, S. I.
Saishoji, T.
Nomura, K.
Sato, H.
author_facet Yamashita, J. I.
Ogawa, M.
Ikei, S.
Omachi, H.
Yamashita, S. I.
Saishoji, T.
Nomura, K.
Sato, H.
author_sort Yamashita, J. I.
collection PubMed
description Breast cancer cells are known to express various proteolytic enzymes, which make them invasive and favour their dissemination to distant sites. However, it is unclear whether breast cancer cells have the ability to produce polymorphonuclear leucocyte elastase (PMN-E). We measured immunoreactive (ir) PMN-E content in the conditioned medium of two breast cancer cell lines, MCF-7 and ZR-75-1, and two normal breast epithelial cell lines, HBL-100 and Hs 578Bst, using a highly specific and sensitive enzyme immunoassay. Furthermore, ir-PMN-E content was determined in tissue extracts from 62 human breast cancers. ir-PMN-E content in the culture medium of MCF-7 cells and ZR-75-1 cells increased as a function of time, regardless of the presence or absence of oestradiol. On the other hand, no detectable ir-PMN-E was secreted into the culture medium of HBL-100 and Hs 578Bst cells. ir-PMN-E was detectable in 59 of 62 tissue extracts prepared from human breast cancers, the concentration ranging from 0.12 to 19.17 micrograms per 100 mg of protein. When 62 breast cancer specimens were categorised into four groups in terms of clinical stage, ir-PMN-E content in breast cancer tissue was significantly higher in stage III (8.90 +/- 5.13 micrograms 100 mg-1 protein) and stage IV (12.19 +/- 5.44 micrograms 100 mg-1 protein) patients than in stage I (1.64 +/- 1.54 micrograms 100 mg-1 protein) and stage II (4.23 +/- 3.74 micrograms 100 mg-1 protein) patients. Breast cancer patients with high levels of ir-PMN-E showed significantly shorter disease-free survival and overall survival than those with low levels of ir-PMN-E at the cut-off point of 8.99 micrograms 100 mg-1 protein. In the multivariate analysis, ir-PMN-E content was found to be a significant prognostic factor for disease recurrence and death in human breast cancer.
format Text
id pubmed-1968785
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19687852009-09-10 Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer. Yamashita, J. I. Ogawa, M. Ikei, S. Omachi, H. Yamashita, S. I. Saishoji, T. Nomura, K. Sato, H. Br J Cancer Research Article Breast cancer cells are known to express various proteolytic enzymes, which make them invasive and favour their dissemination to distant sites. However, it is unclear whether breast cancer cells have the ability to produce polymorphonuclear leucocyte elastase (PMN-E). We measured immunoreactive (ir) PMN-E content in the conditioned medium of two breast cancer cell lines, MCF-7 and ZR-75-1, and two normal breast epithelial cell lines, HBL-100 and Hs 578Bst, using a highly specific and sensitive enzyme immunoassay. Furthermore, ir-PMN-E content was determined in tissue extracts from 62 human breast cancers. ir-PMN-E content in the culture medium of MCF-7 cells and ZR-75-1 cells increased as a function of time, regardless of the presence or absence of oestradiol. On the other hand, no detectable ir-PMN-E was secreted into the culture medium of HBL-100 and Hs 578Bst cells. ir-PMN-E was detectable in 59 of 62 tissue extracts prepared from human breast cancers, the concentration ranging from 0.12 to 19.17 micrograms per 100 mg of protein. When 62 breast cancer specimens were categorised into four groups in terms of clinical stage, ir-PMN-E content in breast cancer tissue was significantly higher in stage III (8.90 +/- 5.13 micrograms 100 mg-1 protein) and stage IV (12.19 +/- 5.44 micrograms 100 mg-1 protein) patients than in stage I (1.64 +/- 1.54 micrograms 100 mg-1 protein) and stage II (4.23 +/- 3.74 micrograms 100 mg-1 protein) patients. Breast cancer patients with high levels of ir-PMN-E showed significantly shorter disease-free survival and overall survival than those with low levels of ir-PMN-E at the cut-off point of 8.99 micrograms 100 mg-1 protein. In the multivariate analysis, ir-PMN-E content was found to be a significant prognostic factor for disease recurrence and death in human breast cancer. Nature Publishing Group 1994-01 /pmc/articles/PMC1968785/ /pubmed/8286213 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Yamashita, J. I.
Ogawa, M.
Ikei, S.
Omachi, H.
Yamashita, S. I.
Saishoji, T.
Nomura, K.
Sato, H.
Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
title Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
title_full Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
title_fullStr Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
title_full_unstemmed Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
title_short Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
title_sort production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968785/
https://www.ncbi.nlm.nih.gov/pubmed/8286213
work_keys_str_mv AT yamashitaji productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer
AT ogawam productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer
AT ikeis productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer
AT omachih productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer
AT yamashitasi productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer
AT saishojit productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer
AT nomurak productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer
AT satoh productionofimmunoreactivepolymorphonuclearleucocyteelastaseinhumanbreastcancercellspossibleroleofpolymorphonuclearleucocyteelastaseintheprogressionofhumanbreastcancer